Alnylam Pharmaceuticals Inc (ALNY) institutional holders · P/E 76, rev $1.29B
Alnylam Pharmaceuticals Inc 13F cache, top 7 holders by reported value.
| Holder | Shares | Value | Report |
|---|---|---|---|
| VANGUARD GROUP INC | 12,397,073 | $4.93T | 2025-12-31 |
| FMR LLC | 10,325,076 | $3.11T | 2026-06-30 |
| STATE STREET CORP | 3,555,689 | $1.07T | 2026-06-30 |
| BlackRock Finance, Inc. | 3,403,971 | $827.16B | 2024-06-30 |
| GOLDMAN SACHS GROUP INC | 378,208 | $125.14B | 2026-03-31 |
| Bridgewater Associates, LP | 99,584 | $29.98B | 2026-06-30 |
| CITADEL ADVISORS LLC | 50,600 | $16.74B | 2026-03-31 |
FAQ
What is ALNY P/E and revenue?
Alnylam Pharmaceuticals Inc (ALNY) P/E 76, rev $1.29B.
Who owns ALNY?
Alnylam Pharmaceuticals Inc cache lists 7 13F holders by reported market value.
Not investment advice. Cached rows, not a live tape.